CompletedNot Applicable

Serum and Uterine Progesterone Levels and ERA Test.

Spain75 participantsStarted 2018-03-13

Plain-language summary

Since the implantation is related with endometrial receptivity, the patient specific plasma progesterone concentration influences this pattern. Following this hypothesis, the study establishes a correlation between the serum progesterone measured on the day of the endometrial biopsy and the endometrial receptivity with the ERA test.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Infertile women \<50 years * One or more failed IVF treatments * Undergoing an artificial endometrial preparation cycle with hormonal replacement therapy in order to perform an endometrial receptivity analysis through ERA test. * Endometrial thickness after estrogen treatment \> 6.5 mm with trilaminar structure Exclusion Criteria: * Uterine alterations (fibroids, polyps or Müllerian abnormalities) * Adnexal pathology

What they're measuring

Progesterone plasma levels and Endometrial receptivity analysis result

Timeframe: 7 months

Trial details

NCT IDNCT03456375

SponsorInstituto Valenciano de Infertilidad, IVI VALENCIA

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-03-15

View on ClinicalTrials.gov More Endometrial Receptivity trials